Revenue and sales volume grew 5.5% year-over-year in H1 2025, with market share gains in all categories. EBITDA margin declined due to one-off costs, but full-year guidance remains positive, supported by new investments and product launches.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.